Make your money go further for just 25p per day

Priced to perfection?

Trustpilot

Results covered here include those of several highly rated smaller companies, including a Main Market constituent which appears to be priced to perfection. Our value pick, surprisingly comes from the normally pricey healthcare sector. An acquisition from an asset manager also leaves us scratching our heads.  (Free to read)


Science in Sport: encouraging, but…..

Sports nutrition specialist Science in Sport (LON:SIS) reported encouraging interim results lifting the shares back close to year highs.

Our previous commentary considered whether Science in Sport was good value and the shares are now up more than 150% since our original note.

For the 6 months ending 30 June, revenue rose 24% to £29.3m with both of the Group’s brands contributing - PhD sales rose 15% to £13.4m and SiS sales were up…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Advanced Medical Solutions

Healthcare advances | Quality in video gaming

19/09/2024 · Company Insights

News covered here includes our assessment of results from a company operating in the healthcare sector.…


Odd name but great results | Director buying | Retailer woes

17/07/2024 · Company Insights

News covered here includes our assessment of excellent results from a provider of a diverse range…


More on Fevertree Drinks

Episode 33 of the Investor’s Champion Podcast

15/09/2024 · Podcasts

In this episode of the Investors Champion Podcast, hosts Lee and Chris focus on news from…


US growth | Legal winner | Dividend delights

13/09/2024 · Company Insights

News covered here includes our assessment of interim results from Fevertree, which disappointed the market, despite…


More on Keywords Studios

Delightful results and special dividend | Bonkers Bargain impresses

28/06/2024 · Company Insights

News covered here includes our assessment of delightfully clean results from one of AIM’s elderly members.…


Episode 20 of the Investor’s Champion Podcast

31/05/2024 · Podcasts

This episode of the Investor’s Champion Podcast focuses on the rampant takeover activity in the UK…


More on Science in Sport

Episode 26 of the Investor’s Champion Podcast

13/07/2024 · Podcasts

In this episode of the Investors Champion Podcast, Chris and Lee cover a range of topics…


Fund raise | Excellent offering | Renewed focus

09/07/2024 · Company Insights

The founder’s return at a provider of vehicle tracking systems has brought renewed focus and improving…


More on Tatton Asset Management

Outrageous remuneration | Fabulous results | Cracking bargain

14/11/2024 · Company Insights

News covered here includes our assessment of fabulous results from an AIM listed investment manager, which…


Episode 23 of the Investor’s Champion Podcast

22/06/2024 · Podcasts

In this episode of the Investors Champion podcast, institutional investors' attraction to private equity and the…


More on Trustpilot

Gaining trust | Cool cosmetics

12/01/2024 · Company Insights

A supplier of modestly priced colour cosmetics continues to impress with another terrific update – the…


Priced to perfection?

15/09/2021 · Company Insights

Results covered here include those of several highly rated smaller companies, including a Main Market constituent…


More Company Insights

Elderly challenges | Demotion | Australian boost

21/11/2024 · Churchill China · CVS Group · Renold · Tracsis

Bonkers Bargains: poised to recover with a new CEO

20/11/2024 · James Cropper

Improving returns | Questionable business models

Sign-up to our free email updates

SIGN UP